Abstract
1. In the present study we have investigated the effects of the relatively low plasma concentrations of gemfibrozil (GFZ) found in clinical practice on the oxygen dissociation curve (ODC) of erythrocytes. 2. ODCs were measured at 30 degrees C and 37 degrees C and at pH 7.4: a) both on HbA solution and erythrocytes incubated in vitro with gemfibrozil and clofibric acid; b) on erythrocytes from healthy volunteers treated with a single oral dose of gemfibrozil. 3. These experiments showed a significant drug-induced shift of the ODC towards lower O2 affinity values without any significant modification of metabolic parameters of erythrocytes such as intracellular pH and intraerythrocytic levels of ATP and DPG. 4. In our experimental conditions gemfibrozil appears to lower both in vitro and in vivo, the partial pressure of oxygen required to give 50% of the haemes saturated with oxygen (P50) of erythrocytes from the control value of 24 +/- 0.5 mm Hg to 29 +/- 0.5 mm Hg (mean +/- s.d.; P < 0.02 by ANOVA). 5. These data clearly indicate that therapeutic doses of gemfibrozil may influence the oxygen transport properties of red cells. This effect could have relevant pharmacological and toxicological implications.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abraham D. J., Perutz M. F., Phillips S. E. Physiological and x-ray studies of potential antisickling agents. Proc Natl Acad Sci U S A. 1983 Jan;80(2):324–328. doi: 10.1073/pnas.80.2.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
- Giardina B., Amiconi G. Measurement of binding of gaseous and nongaseous ligands to hemoglobins by conventional spectrophotometric procedures. Methods Enzymol. 1981;76:417–427. doi: 10.1016/0076-6879(81)76133-0. [DOI] [PubMed] [Google Scholar]
- Hirst D. G., Wood P. J. Could manipulation of the binding affinity of haemoglobin for oxygen be used clinically to sensitize tumours to radiation? Radiother Oncol. 1991;20 (Suppl 1):53–57. doi: 10.1016/0167-8140(91)90188-m. [DOI] [PubMed] [Google Scholar]
- Hyde R. M., Livingstone D. J., Patterson R. A., Batchelor J. F., King W. R. Modification of the haemoglobin oxygen dissociation curve in whole blood by a compound with dual action. Lancet. 1984 Jul 7;2(8393):15–16. doi: 10.1016/s0140-6736(84)92000-2. [DOI] [PubMed] [Google Scholar]
- Manninen V., Elo M. O., Frick M. H., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 1988 Aug 5;260(5):641–651. [PubMed] [Google Scholar]
- Marden M. C., Kister J., Bohn B., Poyart C. T-state hemoglobin with four ligands bound. Biochemistry. 1988 Mar 8;27(5):1659–1664. doi: 10.1021/bi00405a041. [DOI] [PubMed] [Google Scholar]
- Moon R. B., Richards J. H. Determination of intracellular pH by 31P magnetic resonance. J Biol Chem. 1973 Oct 25;248(20):7276–7278. [PubMed] [Google Scholar]
- Perutz M. F., Poyart C. Bezafibrate lowers oxygen affinity of haemoglobin. Lancet. 1983 Oct 15;2(8355):881–882. doi: 10.1016/s0140-6736(83)90870-x. [DOI] [PubMed] [Google Scholar]
- Siemann D. W., Alliet K. L., Macler L. M. Manipulations in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy. Int J Radiat Oncol Biol Phys. 1989 May;16(5):1169–1172. doi: 10.1016/0360-3016(89)90276-9. [DOI] [PubMed] [Google Scholar]